Yanhua Tian

Title: Innovations in Tumor Treatment by Yanhua Tian

Introduction

Yanhua Tian is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for tumors. His work focuses on creating agents that can disrupt tumor blood supply, which is crucial for effective cancer treatment.

Latest Patents

Yanhua Tian holds a patent for a tumor vascular disrupting agent polypeptide, gene, expression vector, and its use. This invention relates to a polypeptide that has a specific amino acid sequence, which includes a truncated tissue factor (tTF) and a tumor-targeting molecule (pHLIP). The design ensures that both components retain their functionality while working together to disrupt blood supply to tumors. This innovative approach has the potential to significantly enhance tumor treatment options.

Career Highlights

Yanhua Tian is associated with Beijing Hua'an Innovation Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the biotechnology sector, focusing on creating effective solutions for cancer treatment.

Collaborations

Yanhua Tian collaborates with esteemed colleagues, including Guangjun Nie and Suping Li, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their innovations in the field of biotechnology.

Conclusion

Yanhua Tian's contributions to tumor treatment through innovative biotechnology are noteworthy. His patent for a tumor vascular disrupting agent represents a significant advancement in cancer therapy. The collaborative efforts with his colleagues further strengthen the potential for impactful developments in this critical area of medicine.